Optical Q™ Fluorescence Immunoassay Analyzer
Quantitative in-vitro FIA rapid diagnostic POCT analyzer
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- Optical Q
- Payment Terms
- T/T
- Production method
- OBM
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- diagnostic devices, ivd, poct, fluorescence immunoassay
South Korea
| Product name | Optical Q™ Fluorescence Immunoassay Analyzer | Certification | CE |
|---|---|---|---|
| Category | Other Monitoring & Diagnostic Equipment | Material | - |
| Keyword | diagnostic devices , ivd , poct , fluorescence immunoassay | Unit Size | - |
| Brand name | Optical Q | Unit Weigh | 4 kg |
| origin | South Korea | Stock | 10000 |
| Supply type | OBM | HS code | 9027 |
Product Information
Optical Q™ is a cutting edge in vitro diagnostics (IVD) fluorescence immunoassay (FIA) point of care (POCT) analyzer that accurately measures the concentration of analytes contained in blood, serum, plasma, and other samples. Results are generated within a prompt 15 minute time frame with CV's ranging from 5%~10%.
In contrast to standard FIA analyzers that use gold nano particles, Optical Q utilizes highly sensitive fluorescent material and incorporates world class lens technology to not only test for the presence of a disease but also accurately quantify the concentration or severity of the disease.
In addition, Optical Q features a wide variety of diagnostic marker - many of which are developed in house that covers health categories including but not limited to inflammation, infection, diabetes, vitamin D deficiency, thyroids, and more. Our capacity to develop our device and antibodies in house enables optimized performance against competitors.
Optical Q is truly a rapid one-stop diagnostic solution.
Optical Q™ features 24 parameters / reagents as seen below:
Inflammation: CRP, PCT
Tumor: AFP, CEA, PSA
Hormone: beta-hCG, LH, FSH, PRL, Cortisol, Testosterone, Progesterone
Thyroid: TSH, Total T3, Free T3, Total T4, Free T4
Cardiac: Myoglobin, CK-MB, D-Dimer, NT-proBNP
Diabetes: HbA1c
Others: Ferritin
COVID-19: Neutralizing antibody (nAb).
| Performance | • Instant results within 3~15 minutes • High CV performance <10% • 24 test parameters and expanding |
| Convenience | • 3 step process: dilute, drop, analyze • Portable weight and size • Modifiable tests |
| Technology | • Top optical lens resolution F/N 1 • RFID for test and lot identification • Internal printer for results |
Specifications
| Test Method | Quantitative Fluorescence Immunoassay |
| CV | <10% |
| Dimensions | 357 mm (L) x 284 mm (W) x 156 mm (H) |
| Weight | 3.5 kg |
| Power Supply | DC 12V/5A, AC/DC Adaptor |
| Data Output | LCD / Internal printer |
| Memory | 99 patient results |
| Interface | RS422 (RJ45) / mini 5pin / USB |
| Display LCD | 5”Mono LCD |
| Working Condition | Temperature: 15-30°C / Humidity: 10-70% |
| Cat No. | Description | Packing Size | Storage Condition |
| OB001 | Optical Q Analyzer | 2 Unit/Carton | Room Temperature |
- Product Info Attached File
- Verified Certificate
-
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Negotiation Other |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | T/T | Shipping time | Negotiable |
- President
- Jeawon Kim, Minyoung Choi
- Address
- Bonbukwan-401, 76, Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Korea
- Product Category
- Other Monitoring & Diagnostic Equipment
- Year Established
- 2019
- Company introduction
-
OptiBio is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and manufacturing cutting edge fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach to immunoassay.
OptiBio's competitive advantage stems from its strong foundation of experts, each specialized in fields crucial for product development. Our R&D is divided into 3 different teams of scientists and engineers dedicated to the independent development of diagnostic markers, test kits, and analyzers.
Our fundamental approach to in-house specialization allows OptiBio to constantly improve our product performance, customize our solutions based on client feedback, develop new test parameters, and respond to changing market needs.
OptiBio will continue to create, improve, and innovate world-class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.
- Main Markets
-
Brazil
Ethiopia
Germany
Mexico
Nigeria
- Main Product
- Attached File
Related Products
Portable, Endoscopic visual system_QVION
AD Tech COVID-19 Ag RAPID KIT
Modular type ENT workstation_XU5 Visual
_2.PNG "Ezplex SARS_CoV_2 FAST G Kit_3")
Ezplex SARS-CoV-2 G Kit (FAST)
InBody770
